Abciximab (3000252900)
From Concept Hub
Concept Properties
| NCID Code | 3000252900 |
|---|---|
| Concept Status | Active (1024) |
| Superceded By | NA |
| Go to edit page: |
|---|
| Definitions |
| Representations |
| + Relationships |
| + Mappings |
Concept Definitions
This concept has the following definitions (descriptions of the meaning of the concept).
| Concept Definition | Language Code | Preferred? |
|---|---|---|
| a platelet aggregation inhibitor used during and after coronary artery procedures to prevent thrombus formation within the coronary artery.
a monoclonal antibody Fab fragment that blocks the platelet glycoprotein IIb/IIIa receptor and potently inhibits platelet aggregation; | en | No |
Representations
This concept has the following representations (also known as designations or surface forms).
| Representation | Languge Code | Preferred? |
|---|---|---|
| <protect>Abciximab</protect> | en | Yes |
| C2101H3229N551O673S15 | en | No |
